First Time Loading...

iSpecimen Inc
NASDAQ:ISPC

Watchlist Manager
iSpecimen Inc Logo
iSpecimen Inc
NASDAQ:ISPC
Watchlist
Price: 0.263 USD -1.31% Market Closed
Updated: May 4, 2024

iSpecimen Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

iSpecimen Inc
Operating Income Peer Comparison

Comparables:
VEEV
INSP
EVH
DOCS
CERT

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
iSpecimen Inc
NASDAQ:ISPC
Operating Income
-$11.2m
CAGR 3-Years
-67%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Operating Income
$429.3m
CAGR 3-Years
4%
CAGR 5-Years
14%
CAGR 10-Years
27%
Inspire Medical Systems Inc
NYSE:INSP
Operating Income
-$40.3m
CAGR 3-Years
11%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Evolent Health Inc
NYSE:EVH
Operating Income
$12.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Operating Income
$125.1m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Certara Inc
NASDAQ:CERT
Operating Income
$6.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is iSpecimen Inc's Operating Income?
Operating Income
-11.2m USD

Based on the financial report for Dec 31, 2023, iSpecimen Inc's Operating Income amounts to -11.2m USD.

What is iSpecimen Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-27%

Over the last year, the Operating Income growth was -14%. The average annual Operating Income growth rates for iSpecimen Inc have been -67% over the past three years , -27% over the past five years .